Study cancer microbes to find test markers
Treatments studied
Part of Cancer clinical trials.
This trial looks at the microbes in your body (mostly from samples) to find clues—called biomarkers—that may help doctors understand or track cancer. You might be asked to share health information and provide samples before or around the time you start cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer and are about to start anticancer treatment
- You can read, understand, and sign the consent form before any study-specific steps
- You are able and willing to follow the study procedures
- You are covered by a social security plan (or a similar coverage program)
- You are not pregnant and not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
This study looks for a new set of urine “markers” (measurable substances in urine) that may help detect cancer earlier. If you join, they will collect your urine and compare results between people with cancer and people without cancer.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This trial studies a blood test that looks for circulating tumor markers in people with any type of invasive cancer (newly diagnosed or suspected). The goal is to see if markers in the blood can help monitor the cancer and guide treatment.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.